相关实验视频
Updated: Jul 6, 2025

06:53
3D Whole-heart Myocardial Tissue Analysis
Published on: April 12, 2017
8.8K
一个治疗缺血性心肌病治疗算法
Raffaele De Caterina1, Riccardo Liga1
1Cardiology Division, Pisa University Hospital and Chair of Cardiology, University of Pisa, Pisa, Italy.
Vascular pharmacology
|January 5, 2024
概括
穿皮冠状动脉干预 (PCI) 可能对缺血性心肌病无效. 冠状动脉旁路移植 (CABG) 可能提供长期预后改善,指导患者选择重血管化.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
背景情况:
- 最近的研究质疑穿皮冠状动脉干预 (PCI) 加上最佳医疗治疗 (OMT) 与仅仅针对缺血性心肌病的OMT的疗效.
- 较旧的试验表明冠状动脉旁路移植 (CABG) 可能在类似的患者群体中提供长期的预后益处.
相关概念视频
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K

